The Global Camostat Mesylate (CAS 59721-29-8) Market was valued at USD 24.5 Million in 2023 and is projected to reach USD 38.7 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period (2023–2028). This growth is being driven by increasing research applications, expanding therapeutic potential, and growing demand across pharmaceutical and scientific research sectors globally.

As the pharmaceutical industry accelerates drug discovery and development, the spotlight is on the key chemical manufacturers and suppliers who are driving quality standards, supply chain reliability, and technical innovation. In this blog, we profile the Top 10 Companies in the Camostat Mesylate Industry—a mix of established chemical manufacturers, specialty suppliers, and research material providers shaping the future of pharmaceutical intermediates.

---

🔟 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Camostat Mesylate (CAS 59721-29-8) in multiple purities

Merck is among the world’s leading life science companies, offering high-purity Camostat Mesylate across global research and pharmaceutical markets. Their chemical division serves academic institutions, pharmaceutical companies, and research organizations with growing investments in pharmaceutical intermediates and research chemicals.

Technical Capabilities:

• Manufacturing high-purity research chemicals
• Global supply chain infrastructure
• ISO 9001 certified production facilities

Download FREE Sample Report: 2023-2028 Global and Regional Camostat Mesylate (CAS 59721-29-8) Industry Status and Prospects Professional Market – View in Detailed Research Report

---

9️⃣ 2. Tokyo Chemical Industry (TCI)

Headquarters: Tokyo, Japan
Key Offering: Camostat Mesylate (CAS 59721-29-8) in 97%, 98%, and 99% purities

TCI operates globally as a leading manufacturer of high-purity chemicals for research and development. It is a significant player in pharmaceutical intermediates, aiming to meet both research and commercial production requirements.

Technical Capabilities:

• Expertise in custom synthesis
• GMP-compliant manufacturing capabilities

---

8️⃣ 3. Biosynth Carbosynth

Headquarters: Staad, Switzerland
Key Offering: Camostat Mesylate (CAS 59721-29-8) for pharmaceutical applications

Biosynth Carbosynth’s chemical division is expanding its pharmaceutical intermediate portfolio with Camostat Mesylate through its global manufacturing network. It is also engaged in analytical method development and quality control support.

Technical Capabilities:

• Research-scale to commercial production
• Technical consultation services

---

7️⃣ 4. Clearsynth

Headquarters: Mumbai, India
Key Offering: High-purity Camostat Mesylate (CAS 59721-29-8)

Clearsynth is one of Asia’s leading suppliers of pharmaceutical reference standards and intermediates, serving both academic research and commercial pharmaceutical sectors.

Technical Capabilities:

• Cost-effective manufacturing solutions
• Regulatory documentation support

Download FREE Sample Report: 2023-2028 Global and Regional Camostat Mesylate (CAS 59721-29-8) Industry Status and Prospects Professional Market – View in Detailed Research Report

---

6️⃣ 5. AK Scientific

Headquarters: Union City, California, USA
Key Offering: Camostat Mesylate (CAS 59721-29-8) in various purities

AK Scientific’s chemical division delivers research chemicals and pharmaceutical intermediates to institutions worldwide. The company provides technical data packages and supports regulatory submissions.

Technical Capabilities:

• Custom synthesis capabilities
• Scale-up manufacturing support

---

5️⃣ 6. Glentham Life Sciences

Headquarters: Corsham, United Kingdom
Key Offering: Pharmaceutical-grade Camostat Mesylate

Glentham Life Sciences specializes in the manufacturing and distribution of fine chemicals and research materials to over 80 countries globally.

Technical Capabilities:

• Established quality control protocols
• Responsive customer technical support

---

4️⃣ 7. BLD Pharmatech

Headquarters: Shanghai, China
Key Offering: Camostat Mesylate (CAS 59721-29-8) in standard and custom purities

BLD Pharmatech serves research institutions and pharmaceutical companies across Asia, Europe, and North America with pharmaceutical intermediates and reference standards.

Technical Capabilities:

• ISO certified manufacturing facilities
• Technical consultation for research applications

---

3️⃣ 8. DC Chemicals

Headquarters: Tianjin, China
Key Offering: Camostat Mesylate in 97%, 98%, and 99% purities

DC Chemicals provides Camostat Mesylate to pharmaceutical manufacturers and research organizations worldwide. It has developed quality control methods and analytical procedures for consistent product quality.

Technical Capabilities:

• Batch-to-batch consistency
• Competitive pricing structure

---

2️⃣ 9. APExBIO Technology

Headquarters: Houston, Texas, USA
Key Offering: Camostat Mesylate for research use

APExBIO specializes in the supply of biochemicals and pharmaceutical intermediates for research and development applications.

Technical Capabilities:

• Focus on research-grade materials
• Technical documentation support

---

1️⃣ 10. Finetech Industry

Headquarters: Nanjing, China
Key Offering: Camostat Mesylate (CAS 59721-29-8) with comprehensive analytical data.

Finetech Industry provides chemical intermediates and research materials to global pharmaceutical and biotechnology companies with established quality systems and regulatory compliance procedures.

Technical Capabilities:

• Technical support for research applications
• Custom synthesis services available

Get Full Report Here: 2023-2028 Global and Regional Camostat Mesylate (CAS 59721-29-8) Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Camostat Mesylate Industry Is Research-Driven and Quality-Focused

The Camostat Mesylate market is undergoing significant transformation. While pharmaceutical applications still dominate in volume, the industry is increasingly focused on analytical method development and regulatory compliance requirements.

📈 Key Trends Shaping the Market:

• Expanding applications in viral research and protease inhibition studies
• Growing demand for high-purity reference standards
• Increasing regulatory requirements for pharmaceutical intermediates
• Rising investment in research and development infrastructure

Get Full Report Here: 2023-2028 Global and Regional Camostat Mesylate (CAS 59721-29-8) Industry Status and Prospects Professional Market – View in Detailed Research Report

The companies listed above are not only supporting pharmaceutical development—they’re enabling the advancement of scientific research globally.